Bio Roundup: Mylan’s Shock, Hillary’s 3%, Duchenne Lessons & More
Xconomy
AUGUST 26, 2016
—A five-day workshop in Washington, D.C., Frank Vinluan has more on Novan, which relied on a variety of high net worth individuals, rather than venture firms, to get to this point. Alex Lash contributed to this report. The company gave no reason for the rejection. Reprints | Share: UNDERWRITERS AND PARTNERS.
40 
Let's personalize your content